Balkhy Hanan H, El-Saed Aiman, Sanai Faisal M, Alqahtani Mohammad, Alonaizi Mashael, Niazy Nermeen, Aljumah Abdulrahman
Department of Infection Prevention and Control, King Abdulaziz Medical City, Riyadh, Saudi Arabia; Gulf Cooperation Council (GCC) States and WHO Collaborating Center for Infection Prevention & Control, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Department of Pediatrics, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Department of Infection Prevention and Control, King Abdulaziz Medical City, Riyadh, Saudi Arabia; Gulf Cooperation Council (GCC) States and WHO Collaborating Center for Infection Prevention & Control, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Community Medicine Department, Faculty of Medicine, Mansoura University, Egypt.
J Infect Public Health. 2017 Jul-Aug;10(4):379-387. doi: 10.1016/j.jiph.2016.06.012. Epub 2016 Oct 6.
Non-adherence with recommended follow-up visits is a major barrier for completing treatment of viral hepatitis and is consequently associated with unfavorable outcomes of health services.
To estimate the magnitude and identify perceived reasons and patient characteristics associated with loss to follow-up in a tertiary care setting.
A two-step cross-sectional study design was used, including a chart review (2011) followed by phone survey (2012). Loss to follow-up was recorded among those who were diagnosed with hepatitis B (HBV) or C (HCV) during 2009-2010 but never returned for recommended/scheduled follow-up appointment(s).
A total of 328 patients (202 HBV and 126 HCV) were included in the current analysis. The average age was 49.6±17.9years, and 57% were males. Out of 328, 131 (40%) were not advised to do follow-up, and 98 (30%) were not doing follow-up. Perceived reasons for loss to follow-up were as follows: unaware that a follow-up appointment was scheduled (69%), never informed of need for follow-up by healthcare provider (15%), personal belief that follow-up was not necessary (9%), logistical reasons (3%) and other reasons (5%). Loss to follow-up was higher among those who had been diagnosed with HBV, referred by non-liver-related specialty, never advised to follow-up, unaware of their diagnosis, incorrectly identified their type of hepatitis, lacking hepatitis complications, having full medical coverage, pregnant, and those with low knowledge or negative attitude towards hepatitis.
Loss to follow-up is a significant problem among patients with hepatitis in a tertiary care center, with several patient and system failures being implicated.
不遵守推荐的随访是完成病毒性肝炎治疗的主要障碍,因此与卫生服务的不良结果相关。
评估三级医疗机构中失访的程度,并确定与失访相关的感知原因和患者特征。
采用两步横断面研究设计,包括图表回顾(2011年),随后进行电话调查(2012年)。对2009 - 2010年期间被诊断为乙型肝炎(HBV)或丙型肝炎(HCV)但从未返回进行推荐/预定随访预约的患者记录失访情况。
本分析共纳入328例患者(202例HBV和126例HCV)。平均年龄为49.6±17.9岁,57%为男性。在328例患者中,131例(40%)未被建议进行随访,98例(30%)未进行随访。失访的感知原因如下:不知道已安排随访预约(69%)、医疗服务提供者从未告知需要随访(15%)、个人认为随访不必要(9%)、后勤原因(3%)和其他原因(5%)。在那些被诊断为HBV、由非肝脏相关专科转诊、从未被建议随访、不知道自己的诊断、错误识别自己的肝炎类型、没有肝炎并发症、有全额医疗保险、怀孕以及对肝炎知识了解少或态度消极的患者中,失访率更高。
在三级医疗机构中,失访是肝炎患者中的一个重要问题,涉及多个患者和系统方面的失误。